TLIS - Talis Biomedical Corp - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TLIS is currently covered by 1 analysts with an average price target of $2.56. This is a potential upside of $0.87 (51.48%) from yesterday's end of day stock price of $1.69.

Talis Biomedical Corp's activity chart (see below) currently has 5 price targets and 5 ratings on display. The stock rating distribution of TLIS is 100% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 79.17% with an average time for these price targets to be met of 182 days.

Highest price target for TLIS is $7, Lowest price target is $7, average price target is $2.56.

Most recent stock forecast was given by MARK MASSARO from BTIG on 16-Aug-2023. First documented stock forecast 09-Mar-2021.

Best performing analysts who are covering TLIS - Talis Biomedical Corp:

Mark Massaro Tycho Peterson Steven Mah Derik De Bruin

Currently out of the existing stock ratings of TLIS, 1 are a SELL (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Sell

$5

$3.15 (170.27%)

$15

1 years 3 months 6 days ago
(16-Aug-2023)

2/3 (66.67%)

$-1.83 (-26.79%)

58

Sell

$22.5

$20.65 (1116.22%)

$45

2 years 8 months 6 days ago
(16-Mar-2022)

2/2 (100%)

$3 (15.38%)

7

Hold

$7

$1.95 (38.61%)

$7

3 years 1 months 22 days ago
(01-Oct-2021)

2/2 (100%)

$0.85 (13.73%)

645

Buy

$9

$3.95 (78.22%)

$13

3 years 3 months 11 days ago
(12-Aug-2021)

1/2 (50%)

$1.45 (14.69%)

18

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is TLIS (Talis Biomedical Corp) average time for price targets to be met?

On average it took 182 days on average for the stock forecasts to be realized with a an average price target met ratio 79.17

Which analyst has the current highest performing score on TLIS (Talis Biomedical Corp) with a proven track record?

MARK MASSARO

Which analyst has the current lower performing score on TLIS (Talis Biomedical Corp) with a proven track record?

DERIK DE BRUIN

Which analyst has the most public recommendations on TLIS (Talis Biomedical Corp)?

Mark Massaro works at BTIG and has 3 price targets and 2 ratings on TLIS

Which analyst is the currently most bullish on TLIS (Talis Biomedical Corp)?

Derik De Bruin with highest potential upside - $20.65

Which analyst is the currently most reserved on TLIS (Talis Biomedical Corp)?

Tycho Peterson with lowest potential downside - $1.95

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?